nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Alkylating Activity—Thiotepa—sarcoma	0.313	0.556	CiPCiCtD
Temozolomide—Alkylating Activity—Dacarbazine—sarcoma	0.25	0.444	CiPCiCtD
Temozolomide—melanoma—sarcoma	0.172	0.518	CtDrD
Temozolomide—skin cancer—sarcoma	0.159	0.482	CtDrD
Temozolomide—CYP3A4—Thiotepa—sarcoma	0.0228	0.458	CbGbCtD
Temozolomide—CYP3A4—Mitoxantrone—sarcoma	0.00979	0.197	CbGbCtD
Temozolomide—CYP3A4—Vincristine—sarcoma	0.00674	0.136	CbGbCtD
Temozolomide—CYP3A4—Etoposide—sarcoma	0.00617	0.124	CbGbCtD
Temozolomide—CYP3A4—Doxorubicin—sarcoma	0.00421	0.0848	CbGbCtD
Temozolomide—Abdominal pain—Mitoxantrone—sarcoma	3.86e-05	0.000695	CcSEcCtD
Temozolomide—Body temperature increased—Mitoxantrone—sarcoma	3.86e-05	0.000695	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	3.86e-05	0.000695	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Doxorubicin—sarcoma	3.86e-05	0.000695	CcSEcCtD
Temozolomide—Bronchitis—Epirubicin—sarcoma	3.85e-05	0.000693	CcSEcCtD
Temozolomide—Diarrhoea—Dactinomycin—sarcoma	3.84e-05	0.000691	CcSEcCtD
Temozolomide—Pancytopenia—Epirubicin—sarcoma	3.8e-05	0.000684	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Doxorubicin—sarcoma	3.78e-05	0.00068	CcSEcCtD
Temozolomide—Muscular weakness—Doxorubicin—sarcoma	3.78e-05	0.00068	CcSEcCtD
Temozolomide—Dysuria—Epirubicin—sarcoma	3.74e-05	0.000674	CcSEcCtD
Temozolomide—Neutropenia—Epirubicin—sarcoma	3.74e-05	0.000674	CcSEcCtD
Temozolomide—Dizziness—Thiotepa—sarcoma	3.74e-05	0.000673	CcSEcCtD
Temozolomide—Abdominal distension—Doxorubicin—sarcoma	3.73e-05	0.000671	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Epirubicin—sarcoma	3.72e-05	0.00067	CcSEcCtD
Temozolomide—Dysphagia—Doxorubicin—sarcoma	3.7e-05	0.000667	CcSEcCtD
Temozolomide—Pollakiuria—Epirubicin—sarcoma	3.7e-05	0.000666	CcSEcCtD
Temozolomide—Hypersensitivity—Vincristine—sarcoma	3.69e-05	0.000665	CcSEcCtD
Temozolomide—Photosensitivity reaction—Epirubicin—sarcoma	3.65e-05	0.000658	CcSEcCtD
Temozolomide—Paraesthesia—Etoposide—sarcoma	3.64e-05	0.000656	CcSEcCtD
Temozolomide—Weight increased—Epirubicin—sarcoma	3.64e-05	0.000656	CcSEcCtD
Temozolomide—Weight decreased—Epirubicin—sarcoma	3.62e-05	0.000652	CcSEcCtD
Temozolomide—Dyspnoea—Etoposide—sarcoma	3.62e-05	0.000652	CcSEcCtD
Temozolomide—Hyperglycaemia—Epirubicin—sarcoma	3.61e-05	0.00065	CcSEcCtD
Temozolomide—Somnolence—Etoposide—sarcoma	3.61e-05	0.00065	CcSEcCtD
Temozolomide—Hypersensitivity—Mitoxantrone—sarcoma	3.59e-05	0.000647	CcSEcCtD
Temozolomide—Asthenia—Vincristine—sarcoma	3.59e-05	0.000647	CcSEcCtD
Temozolomide—Vomiting—Thiotepa—sarcoma	3.59e-05	0.000647	CcSEcCtD
Temozolomide—Pneumonia—Epirubicin—sarcoma	3.59e-05	0.000646	CcSEcCtD
Temozolomide—Infestation NOS—Epirubicin—sarcoma	3.57e-05	0.000642	CcSEcCtD
Temozolomide—Infestation—Epirubicin—sarcoma	3.57e-05	0.000642	CcSEcCtD
Temozolomide—Vomiting—Dactinomycin—sarcoma	3.57e-05	0.000642	CcSEcCtD
Temozolomide—Rash—Thiotepa—sarcoma	3.56e-05	0.000642	CcSEcCtD
Temozolomide—Bronchitis—Doxorubicin—sarcoma	3.56e-05	0.000641	CcSEcCtD
Temozolomide—Dermatitis—Thiotepa—sarcoma	3.56e-05	0.000641	CcSEcCtD
Temozolomide—Headache—Thiotepa—sarcoma	3.54e-05	0.000637	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Epirubicin—sarcoma	3.54e-05	0.000637	CcSEcCtD
Temozolomide—Rash—Dactinomycin—sarcoma	3.54e-05	0.000637	CcSEcCtD
Temozolomide—Decreased appetite—Etoposide—sarcoma	3.53e-05	0.000635	CcSEcCtD
Temozolomide—Pancytopenia—Doxorubicin—sarcoma	3.52e-05	0.000633	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Etoposide—sarcoma	3.5e-05	0.000631	CcSEcCtD
Temozolomide—Asthenia—Mitoxantrone—sarcoma	3.5e-05	0.00063	CcSEcCtD
Temozolomide—Fatigue—Etoposide—sarcoma	3.5e-05	0.00063	CcSEcCtD
Temozolomide—Neuropathy peripheral—Epirubicin—sarcoma	3.5e-05	0.00063	CcSEcCtD
Temozolomide—Stomatitis—Epirubicin—sarcoma	3.48e-05	0.000626	CcSEcCtD
Temozolomide—Pain—Etoposide—sarcoma	3.47e-05	0.000625	CcSEcCtD
Temozolomide—Constipation—Etoposide—sarcoma	3.47e-05	0.000625	CcSEcCtD
Temozolomide—Urinary tract infection—Epirubicin—sarcoma	3.47e-05	0.000624	CcSEcCtD
Temozolomide—Dysuria—Doxorubicin—sarcoma	3.46e-05	0.000623	CcSEcCtD
Temozolomide—Neutropenia—Doxorubicin—sarcoma	3.46e-05	0.000623	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Doxorubicin—sarcoma	3.44e-05	0.00062	CcSEcCtD
Temozolomide—Diarrhoea—Vincristine—sarcoma	3.43e-05	0.000617	CcSEcCtD
Temozolomide—Pollakiuria—Doxorubicin—sarcoma	3.42e-05	0.000616	CcSEcCtD
Temozolomide—Photosensitivity reaction—Doxorubicin—sarcoma	3.38e-05	0.000608	CcSEcCtD
Temozolomide—Hepatobiliary disease—Epirubicin—sarcoma	3.37e-05	0.000608	CcSEcCtD
Temozolomide—Weight increased—Doxorubicin—sarcoma	3.37e-05	0.000607	CcSEcCtD
Temozolomide—Nausea—Thiotepa—sarcoma	3.36e-05	0.000604	CcSEcCtD
Temozolomide—Weight decreased—Doxorubicin—sarcoma	3.35e-05	0.000603	CcSEcCtD
Temozolomide—Sinusitis—Epirubicin—sarcoma	3.35e-05	0.000603	CcSEcCtD
Temozolomide—Feeling abnormal—Etoposide—sarcoma	3.34e-05	0.000602	CcSEcCtD
Temozolomide—Hyperglycaemia—Doxorubicin—sarcoma	3.34e-05	0.000601	CcSEcCtD
Temozolomide—Diarrhoea—Mitoxantrone—sarcoma	3.34e-05	0.000601	CcSEcCtD
Temozolomide—Nausea—Dactinomycin—sarcoma	3.33e-05	0.0006	CcSEcCtD
Temozolomide—Pneumonia—Doxorubicin—sarcoma	3.32e-05	0.000598	CcSEcCtD
Temozolomide—Gastrointestinal pain—Etoposide—sarcoma	3.32e-05	0.000598	CcSEcCtD
Temozolomide—Dizziness—Vincristine—sarcoma	3.31e-05	0.000597	CcSEcCtD
Temozolomide—Infestation NOS—Doxorubicin—sarcoma	3.3e-05	0.000594	CcSEcCtD
Temozolomide—Infestation—Doxorubicin—sarcoma	3.3e-05	0.000594	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	3.27e-05	0.000589	CcSEcCtD
Temozolomide—Neuropathy peripheral—Doxorubicin—sarcoma	3.24e-05	0.000583	CcSEcCtD
Temozolomide—Urticaria—Etoposide—sarcoma	3.22e-05	0.000581	CcSEcCtD
Temozolomide—Haemoglobin—Epirubicin—sarcoma	3.22e-05	0.00058	CcSEcCtD
Temozolomide—Stomatitis—Doxorubicin—sarcoma	3.22e-05	0.000579	CcSEcCtD
Temozolomide—Abdominal pain—Etoposide—sarcoma	3.21e-05	0.000578	CcSEcCtD
Temozolomide—Body temperature increased—Etoposide—sarcoma	3.21e-05	0.000578	CcSEcCtD
Temozolomide—Urinary tract infection—Doxorubicin—sarcoma	3.21e-05	0.000578	CcSEcCtD
Temozolomide—Hepatitis—Epirubicin—sarcoma	3.2e-05	0.000577	CcSEcCtD
Temozolomide—Haemorrhage—Epirubicin—sarcoma	3.2e-05	0.000577	CcSEcCtD
Temozolomide—Hypoaesthesia—Epirubicin—sarcoma	3.19e-05	0.000574	CcSEcCtD
Temozolomide—Vomiting—Vincristine—sarcoma	3.19e-05	0.000574	CcSEcCtD
Temozolomide—Pharyngitis—Epirubicin—sarcoma	3.18e-05	0.000572	CcSEcCtD
Temozolomide—Urinary tract disorder—Epirubicin—sarcoma	3.16e-05	0.000569	CcSEcCtD
Temozolomide—Rash—Vincristine—sarcoma	3.16e-05	0.000569	CcSEcCtD
Temozolomide—Dermatitis—Vincristine—sarcoma	3.16e-05	0.000568	CcSEcCtD
Temozolomide—Oedema peripheral—Epirubicin—sarcoma	3.15e-05	0.000568	CcSEcCtD
Temozolomide—Connective tissue disorder—Epirubicin—sarcoma	3.15e-05	0.000567	CcSEcCtD
Temozolomide—Urethral disorder—Epirubicin—sarcoma	3.14e-05	0.000565	CcSEcCtD
Temozolomide—Headache—Vincristine—sarcoma	3.14e-05	0.000565	CcSEcCtD
Temozolomide—Hepatobiliary disease—Doxorubicin—sarcoma	3.12e-05	0.000562	CcSEcCtD
Temozolomide—Vomiting—Mitoxantrone—sarcoma	3.1e-05	0.000559	CcSEcCtD
Temozolomide—Sinusitis—Doxorubicin—sarcoma	3.1e-05	0.000558	CcSEcCtD
Temozolomide—Visual impairment—Epirubicin—sarcoma	3.09e-05	0.000556	CcSEcCtD
Temozolomide—Rash—Mitoxantrone—sarcoma	3.08e-05	0.000554	CcSEcCtD
Temozolomide—Dermatitis—Mitoxantrone—sarcoma	3.07e-05	0.000553	CcSEcCtD
Temozolomide—Headache—Mitoxantrone—sarcoma	3.06e-05	0.00055	CcSEcCtD
Temozolomide—Erythema multiforme—Epirubicin—sarcoma	3.03e-05	0.000545	CcSEcCtD
Temozolomide—Eye disorder—Epirubicin—sarcoma	2.99e-05	0.000539	CcSEcCtD
Temozolomide—Hypersensitivity—Etoposide—sarcoma	2.99e-05	0.000538	CcSEcCtD
Temozolomide—Tinnitus—Epirubicin—sarcoma	2.99e-05	0.000538	CcSEcCtD
Temozolomide—Haemoglobin—Doxorubicin—sarcoma	2.98e-05	0.000536	CcSEcCtD
Temozolomide—Nausea—Vincristine—sarcoma	2.98e-05	0.000536	CcSEcCtD
Temozolomide—Cardiac disorder—Epirubicin—sarcoma	2.97e-05	0.000535	CcSEcCtD
Temozolomide—Flushing—Epirubicin—sarcoma	2.97e-05	0.000535	CcSEcCtD
Temozolomide—Haemorrhage—Doxorubicin—sarcoma	2.96e-05	0.000534	CcSEcCtD
Temozolomide—Hepatitis—Doxorubicin—sarcoma	2.96e-05	0.000534	CcSEcCtD
Temozolomide—Hypoaesthesia—Doxorubicin—sarcoma	2.95e-05	0.000531	CcSEcCtD
Temozolomide—Pharyngitis—Doxorubicin—sarcoma	2.94e-05	0.00053	CcSEcCtD
Temozolomide—Urinary tract disorder—Doxorubicin—sarcoma	2.93e-05	0.000527	CcSEcCtD
Temozolomide—Oedema peripheral—Doxorubicin—sarcoma	2.92e-05	0.000526	CcSEcCtD
Temozolomide—Asthenia—Etoposide—sarcoma	2.91e-05	0.000524	CcSEcCtD
Temozolomide—Connective tissue disorder—Doxorubicin—sarcoma	2.91e-05	0.000524	CcSEcCtD
Temozolomide—Angiopathy—Epirubicin—sarcoma	2.91e-05	0.000523	CcSEcCtD
Temozolomide—Urethral disorder—Doxorubicin—sarcoma	2.9e-05	0.000523	CcSEcCtD
Temozolomide—Nausea—Mitoxantrone—sarcoma	2.9e-05	0.000522	CcSEcCtD
Temozolomide—Immune system disorder—Epirubicin—sarcoma	2.89e-05	0.000521	CcSEcCtD
Temozolomide—Mediastinal disorder—Epirubicin—sarcoma	2.89e-05	0.00052	CcSEcCtD
Temozolomide—Chills—Epirubicin—sarcoma	2.87e-05	0.000517	CcSEcCtD
Temozolomide—Pruritus—Etoposide—sarcoma	2.87e-05	0.000517	CcSEcCtD
Temozolomide—Visual impairment—Doxorubicin—sarcoma	2.86e-05	0.000514	CcSEcCtD
Temozolomide—Alopecia—Epirubicin—sarcoma	2.83e-05	0.00051	CcSEcCtD
Temozolomide—Mental disorder—Epirubicin—sarcoma	2.81e-05	0.000505	CcSEcCtD
Temozolomide—Erythema multiforme—Doxorubicin—sarcoma	2.8e-05	0.000504	CcSEcCtD
Temozolomide—Erythema—Epirubicin—sarcoma	2.79e-05	0.000502	CcSEcCtD
Temozolomide—Malnutrition—Epirubicin—sarcoma	2.79e-05	0.000502	CcSEcCtD
Temozolomide—Diarrhoea—Etoposide—sarcoma	2.78e-05	0.0005	CcSEcCtD
Temozolomide—Eye disorder—Doxorubicin—sarcoma	2.77e-05	0.000499	CcSEcCtD
Temozolomide—Tinnitus—Doxorubicin—sarcoma	2.76e-05	0.000497	CcSEcCtD
Temozolomide—Cardiac disorder—Doxorubicin—sarcoma	2.75e-05	0.000495	CcSEcCtD
Temozolomide—Flushing—Doxorubicin—sarcoma	2.75e-05	0.000495	CcSEcCtD
Temozolomide—Dysgeusia—Epirubicin—sarcoma	2.73e-05	0.000492	CcSEcCtD
Temozolomide—Back pain—Epirubicin—sarcoma	2.7e-05	0.000486	CcSEcCtD
Temozolomide—Angiopathy—Doxorubicin—sarcoma	2.69e-05	0.000484	CcSEcCtD
Temozolomide—Dizziness—Etoposide—sarcoma	2.68e-05	0.000483	CcSEcCtD
Temozolomide—Immune system disorder—Doxorubicin—sarcoma	2.68e-05	0.000482	CcSEcCtD
Temozolomide—Mediastinal disorder—Doxorubicin—sarcoma	2.67e-05	0.000481	CcSEcCtD
Temozolomide—Chills—Doxorubicin—sarcoma	2.66e-05	0.000479	CcSEcCtD
Temozolomide—Vision blurred—Epirubicin—sarcoma	2.63e-05	0.000473	CcSEcCtD
Temozolomide—Alopecia—Doxorubicin—sarcoma	2.62e-05	0.000471	CcSEcCtD
Temozolomide—Mental disorder—Doxorubicin—sarcoma	2.6e-05	0.000467	CcSEcCtD
Temozolomide—Ill-defined disorder—Epirubicin—sarcoma	2.59e-05	0.000466	CcSEcCtD
Temozolomide—Vomiting—Etoposide—sarcoma	2.58e-05	0.000465	CcSEcCtD
Temozolomide—Erythema—Doxorubicin—sarcoma	2.58e-05	0.000464	CcSEcCtD
Temozolomide—Malnutrition—Doxorubicin—sarcoma	2.58e-05	0.000464	CcSEcCtD
Temozolomide—Anaemia—Epirubicin—sarcoma	2.58e-05	0.000464	CcSEcCtD
Temozolomide—Agitation—Epirubicin—sarcoma	2.56e-05	0.000461	CcSEcCtD
Temozolomide—Rash—Etoposide—sarcoma	2.56e-05	0.000461	CcSEcCtD
Temozolomide—Dermatitis—Etoposide—sarcoma	2.56e-05	0.00046	CcSEcCtD
Temozolomide—Headache—Etoposide—sarcoma	2.54e-05	0.000458	CcSEcCtD
Temozolomide—Dysgeusia—Doxorubicin—sarcoma	2.53e-05	0.000455	CcSEcCtD
Temozolomide—Malaise—Epirubicin—sarcoma	2.51e-05	0.000453	CcSEcCtD
Temozolomide—Vertigo—Epirubicin—sarcoma	2.5e-05	0.000451	CcSEcCtD
Temozolomide—Leukopenia—Epirubicin—sarcoma	2.5e-05	0.000449	CcSEcCtD
Temozolomide—Back pain—Doxorubicin—sarcoma	2.49e-05	0.000449	CcSEcCtD
Temozolomide—Palpitations—Epirubicin—sarcoma	2.46e-05	0.000444	CcSEcCtD
Temozolomide—Cough—Epirubicin—sarcoma	2.43e-05	0.000438	CcSEcCtD
Temozolomide—Vision blurred—Doxorubicin—sarcoma	2.43e-05	0.000438	CcSEcCtD
Temozolomide—Convulsion—Epirubicin—sarcoma	2.42e-05	0.000435	CcSEcCtD
Temozolomide—Nausea—Etoposide—sarcoma	2.41e-05	0.000434	CcSEcCtD
Temozolomide—Hypertension—Epirubicin—sarcoma	2.41e-05	0.000433	CcSEcCtD
Temozolomide—Ill-defined disorder—Doxorubicin—sarcoma	2.39e-05	0.000431	CcSEcCtD
Temozolomide—Anaemia—Doxorubicin—sarcoma	2.38e-05	0.000429	CcSEcCtD
Temozolomide—Arthralgia—Epirubicin—sarcoma	2.37e-05	0.000427	CcSEcCtD
Temozolomide—Myalgia—Epirubicin—sarcoma	2.37e-05	0.000427	CcSEcCtD
Temozolomide—Agitation—Doxorubicin—sarcoma	2.37e-05	0.000427	CcSEcCtD
Temozolomide—Anxiety—Epirubicin—sarcoma	2.36e-05	0.000426	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	2.36e-05	0.000424	CcSEcCtD
Temozolomide—Discomfort—Epirubicin—sarcoma	2.34e-05	0.000422	CcSEcCtD
Temozolomide—Malaise—Doxorubicin—sarcoma	2.33e-05	0.000419	CcSEcCtD
Temozolomide—Dry mouth—Epirubicin—sarcoma	2.32e-05	0.000418	CcSEcCtD
Temozolomide—Vertigo—Doxorubicin—sarcoma	2.32e-05	0.000417	CcSEcCtD
Temozolomide—Leukopenia—Doxorubicin—sarcoma	2.31e-05	0.000416	CcSEcCtD
Temozolomide—Confusional state—Epirubicin—sarcoma	2.29e-05	0.000413	CcSEcCtD
Temozolomide—Palpitations—Doxorubicin—sarcoma	2.28e-05	0.00041	CcSEcCtD
Temozolomide—Anaphylactic shock—Epirubicin—sarcoma	2.27e-05	0.00041	CcSEcCtD
Temozolomide—Oedema—Epirubicin—sarcoma	2.27e-05	0.00041	CcSEcCtD
Temozolomide—Infection—Epirubicin—sarcoma	2.26e-05	0.000407	CcSEcCtD
Temozolomide—Cough—Doxorubicin—sarcoma	2.25e-05	0.000405	CcSEcCtD
Temozolomide—Convulsion—Doxorubicin—sarcoma	2.23e-05	0.000402	CcSEcCtD
Temozolomide—Nervous system disorder—Epirubicin—sarcoma	2.23e-05	0.000402	CcSEcCtD
Temozolomide—Thrombocytopenia—Epirubicin—sarcoma	2.23e-05	0.000401	CcSEcCtD
Temozolomide—Hypertension—Doxorubicin—sarcoma	2.23e-05	0.000401	CcSEcCtD
Temozolomide—Skin disorder—Epirubicin—sarcoma	2.21e-05	0.000398	CcSEcCtD
Temozolomide—Hyperhidrosis—Epirubicin—sarcoma	2.2e-05	0.000396	CcSEcCtD
Temozolomide—Arthralgia—Doxorubicin—sarcoma	2.2e-05	0.000395	CcSEcCtD
Temozolomide—Myalgia—Doxorubicin—sarcoma	2.2e-05	0.000395	CcSEcCtD
Temozolomide—Anxiety—Doxorubicin—sarcoma	2.19e-05	0.000394	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	2.18e-05	0.000393	CcSEcCtD
Temozolomide—Discomfort—Doxorubicin—sarcoma	2.17e-05	0.000391	CcSEcCtD
Temozolomide—Anorexia—Epirubicin—sarcoma	2.17e-05	0.000391	CcSEcCtD
Temozolomide—Dry mouth—Doxorubicin—sarcoma	2.15e-05	0.000387	CcSEcCtD
Temozolomide—Confusional state—Doxorubicin—sarcoma	2.12e-05	0.000382	CcSEcCtD
Temozolomide—Anaphylactic shock—Doxorubicin—sarcoma	2.1e-05	0.000379	CcSEcCtD
Temozolomide—Oedema—Doxorubicin—sarcoma	2.1e-05	0.000379	CcSEcCtD
Temozolomide—Infection—Doxorubicin—sarcoma	2.09e-05	0.000377	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Epirubicin—sarcoma	2.07e-05	0.000373	CcSEcCtD
Temozolomide—Nervous system disorder—Doxorubicin—sarcoma	2.06e-05	0.000372	CcSEcCtD
Temozolomide—Thrombocytopenia—Doxorubicin—sarcoma	2.06e-05	0.000371	CcSEcCtD
Temozolomide—Insomnia—Epirubicin—sarcoma	2.06e-05	0.000371	CcSEcCtD
Temozolomide—Skin disorder—Doxorubicin—sarcoma	2.04e-05	0.000368	CcSEcCtD
Temozolomide—Paraesthesia—Epirubicin—sarcoma	2.04e-05	0.000368	CcSEcCtD
Temozolomide—Hyperhidrosis—Doxorubicin—sarcoma	2.03e-05	0.000366	CcSEcCtD
Temozolomide—Dyspnoea—Epirubicin—sarcoma	2.03e-05	0.000365	CcSEcCtD
Temozolomide—Somnolence—Epirubicin—sarcoma	2.02e-05	0.000364	CcSEcCtD
Temozolomide—Anorexia—Doxorubicin—sarcoma	2.01e-05	0.000361	CcSEcCtD
Temozolomide—Dyspepsia—Epirubicin—sarcoma	2e-05	0.000361	CcSEcCtD
Temozolomide—Decreased appetite—Epirubicin—sarcoma	1.98e-05	0.000356	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Epirubicin—sarcoma	1.96e-05	0.000354	CcSEcCtD
Temozolomide—Fatigue—Epirubicin—sarcoma	1.96e-05	0.000353	CcSEcCtD
Temozolomide—Pain—Epirubicin—sarcoma	1.95e-05	0.00035	CcSEcCtD
Temozolomide—Constipation—Epirubicin—sarcoma	1.95e-05	0.00035	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Doxorubicin—sarcoma	1.92e-05	0.000345	CcSEcCtD
Temozolomide—Insomnia—Doxorubicin—sarcoma	1.9e-05	0.000343	CcSEcCtD
Temozolomide—Paraesthesia—Doxorubicin—sarcoma	1.89e-05	0.00034	CcSEcCtD
Temozolomide—Dyspnoea—Doxorubicin—sarcoma	1.88e-05	0.000338	CcSEcCtD
Temozolomide—Feeling abnormal—Epirubicin—sarcoma	1.87e-05	0.000338	CcSEcCtD
Temozolomide—Somnolence—Doxorubicin—sarcoma	1.87e-05	0.000337	CcSEcCtD
Temozolomide—Gastrointestinal pain—Epirubicin—sarcoma	1.86e-05	0.000335	CcSEcCtD
Temozolomide—Dyspepsia—Doxorubicin—sarcoma	1.85e-05	0.000334	CcSEcCtD
Temozolomide—Decreased appetite—Doxorubicin—sarcoma	1.83e-05	0.00033	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Doxorubicin—sarcoma	1.82e-05	0.000327	CcSEcCtD
Temozolomide—Fatigue—Doxorubicin—sarcoma	1.81e-05	0.000327	CcSEcCtD
Temozolomide—Urticaria—Epirubicin—sarcoma	1.81e-05	0.000325	CcSEcCtD
Temozolomide—Pain—Doxorubicin—sarcoma	1.8e-05	0.000324	CcSEcCtD
Temozolomide—Constipation—Doxorubicin—sarcoma	1.8e-05	0.000324	CcSEcCtD
Temozolomide—Abdominal pain—Epirubicin—sarcoma	1.8e-05	0.000324	CcSEcCtD
Temozolomide—Body temperature increased—Epirubicin—sarcoma	1.8e-05	0.000324	CcSEcCtD
Temozolomide—Feeling abnormal—Doxorubicin—sarcoma	1.73e-05	0.000312	CcSEcCtD
Temozolomide—Gastrointestinal pain—Doxorubicin—sarcoma	1.72e-05	0.00031	CcSEcCtD
Temozolomide—Hypersensitivity—Epirubicin—sarcoma	1.68e-05	0.000302	CcSEcCtD
Temozolomide—Urticaria—Doxorubicin—sarcoma	1.67e-05	0.000301	CcSEcCtD
Temozolomide—Body temperature increased—Doxorubicin—sarcoma	1.66e-05	0.0003	CcSEcCtD
Temozolomide—Abdominal pain—Doxorubicin—sarcoma	1.66e-05	0.0003	CcSEcCtD
Temozolomide—Asthenia—Epirubicin—sarcoma	1.63e-05	0.000294	CcSEcCtD
Temozolomide—Pruritus—Epirubicin—sarcoma	1.61e-05	0.00029	CcSEcCtD
Temozolomide—Diarrhoea—Epirubicin—sarcoma	1.56e-05	0.00028	CcSEcCtD
Temozolomide—Hypersensitivity—Doxorubicin—sarcoma	1.55e-05	0.000279	CcSEcCtD
Temozolomide—Asthenia—Doxorubicin—sarcoma	1.51e-05	0.000272	CcSEcCtD
Temozolomide—Dizziness—Epirubicin—sarcoma	1.5e-05	0.000271	CcSEcCtD
Temozolomide—Pruritus—Doxorubicin—sarcoma	1.49e-05	0.000268	CcSEcCtD
Temozolomide—Vomiting—Epirubicin—sarcoma	1.45e-05	0.00026	CcSEcCtD
Temozolomide—Diarrhoea—Doxorubicin—sarcoma	1.44e-05	0.000259	CcSEcCtD
Temozolomide—Rash—Epirubicin—sarcoma	1.43e-05	0.000258	CcSEcCtD
Temozolomide—Dermatitis—Epirubicin—sarcoma	1.43e-05	0.000258	CcSEcCtD
Temozolomide—Headache—Epirubicin—sarcoma	1.43e-05	0.000257	CcSEcCtD
Temozolomide—Dizziness—Doxorubicin—sarcoma	1.39e-05	0.000251	CcSEcCtD
Temozolomide—Nausea—Epirubicin—sarcoma	1.35e-05	0.000243	CcSEcCtD
Temozolomide—Vomiting—Doxorubicin—sarcoma	1.34e-05	0.000241	CcSEcCtD
Temozolomide—Rash—Doxorubicin—sarcoma	1.33e-05	0.000239	CcSEcCtD
Temozolomide—Dermatitis—Doxorubicin—sarcoma	1.33e-05	0.000239	CcSEcCtD
Temozolomide—Headache—Doxorubicin—sarcoma	1.32e-05	0.000237	CcSEcCtD
Temozolomide—Nausea—Doxorubicin—sarcoma	1.25e-05	0.000225	CcSEcCtD
